We evaluated the expression of human trophoblast cell-surface marker (Trop-2) and the potential of hRS7, a humanized monoclonal anti-Trop-2 antibody, against treatment-refractory cervical cancer.

Cervical carcinomas overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody

BELLONE, Stefania;PECORELLI, Sergio;
2012-01-01

Abstract

We evaluated the expression of human trophoblast cell-surface marker (Trop-2) and the potential of hRS7, a humanized monoclonal anti-Trop-2 antibody, against treatment-refractory cervical cancer.
2012
Inglese
205
6
567.e1-7
Adenocarcinoma; Adult; Antibodies, Monoclonal; Antigens, Neoplasm; Carcinoma, Squamous Cell; Cell Adhesion Molecules; Cell Line, Tumor; Complement System Proteins; Drug Resistance, Neoplasm; Drug Synergism; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Immunoglobulin G; Interleukin-2; Killer Cells, Natural; Real-Time Polymerase Chain Reaction; Tumor Markers, Biological; Uterine Cervical Neoplasms
11
info:eu-repo/semantics/article
262
Varughese, Joyce; Cocco, Emiliano; Bellone, Stefania; Ratner, Elena; Silasi, Dan Arin; Azodi, Masoud; Schwartz, Peter E; Rutherford, Thomas J; Buza, N...espandi
1 Contributo su Rivista::1.1 Articolo in rivista
none
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11379/457298
Citazioni
  • ???jsp.display-item.citation.pmc??? 27
  • Scopus 43
  • ???jsp.display-item.citation.isi??? 41
social impact